Biosimilars in Europe and the U.S.

Attention and focus on biosimilars extends well beyond U.S. shores, in London this week (Nov. 23-24), the Biosimilars Europe Congress is gathering for its second conference. The EU approved the first biosimilar medicine in 2006, and to date has approved the highest number of biosimilars worldwide.  While the U.S. has approved seven biosimilars to date – the EU has approved more than four times the number of biosimilar drugs.

Read about the upcoming conference in London as well as an update on the approval of pending biosimilar applications in Europe and the U.S.

Biosimilars Europe Congress
Update on Biosimilar Approvals and Pending Applications in Europe and the U.S.

Become a Member

Whether you have an established practice, you’re fresh out of your fellowship, or you’re a hospital-based rheumatologist considering private practice, United Rheumatology offers the resources and services you need to advance your career and your clinic.


Find a UR Rheumatologist Near Me

© 2023 United Rheumatology